Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Green Fresh Biotechnology CoHKSE:01084 -2.86%52 Return-on-Tangible-Equity is 5.26% as of Dec. 2025, which is 72% below its 10-year median of 18.46. GuruFocus rates HKSE:01084 with a GF Score™ of 52/100 and a GF Value™ of HK$0.55 (Modestly Overvalued). The stock has 10 warning signs investors should review. Among 1,884 Consumer Packaged Goods companies, Green Fresh Biotechnology Co ranks worse than 74.2% on this metric.
Return-on-Tangible-Equity is calculated as Net Income divided by its average total shareholder tangible equity. Total shareholder tangible equity equals to Total Stockholders Equity minus Intangible Assets. Green Fresh Biotechnology Co's annualized net income for the quarter that ended in Dec. 2025 was HK$41.2 Mil. Green Fresh Biotechnology Co's average shareholder tangible equity for the quarter that ended in Dec. 2025 was HK$784.3 Mil. Therefore, Green Fresh Biotechnology Co's annualized Return-on-Tangible-Equity for the quarter that ended in Dec. 2025 was 5.26%.
The historical rank and industry rank for Green Fresh Biotechnology Co's Return-on-Tangible-Equity or its related term are showing as below:
HKSE:01084'
s Return-on-Tangible-Equity Range Over the Past 10 Years
Min: -12.53 Med: 18.46 Max: 68.02
Current: 0.95
During the past 10 years, Green Fresh Biotechnology Co's highest Return-on-Tangible-Equity was 68.02%. The lowest was -12.53%. And the median was 18.46%.
HKSE:01084's Return-on-Tangible-Equity is ranked worse than 74.2% of 1884
companies
in the Consumer Packaged Goods industry
Industry Median: 8.04
vs HKSE:01084: 0.95
Green Fresh Biotechnology Co (HKSE:01084) Return-on-Tangible-Equity Explanation
Return-on-Tangible-Equity measures the rate of return on the ownership interest (shareholder's tangible equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' tangible equity (shareholders equity minus intangibles). Return-on-Tangible-Equity shows how well a company uses investment funds to generate earnings growth. Return-on-Tangible-Equitys between 15% and 20% are considered desirable.
Be Aware
Net Income is used.
Because a company can increase its Return-on-Tangible-Equity by having more financial leverage, it is important to watch the leverage ratio when investing in high Return-on-Tangible-Equity companies. Like Return-on-Tangible-Asset, Return-on-Tangible-Equity is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.
Asset light businesses require very few assets to generate very high earnings. Their Return-on-Tangible-Equitys can be extremely high.
Green Fresh Biotechnology Co Return-on-Tangible-Equity Related Terms
Green Fresh Biotechnology Co Return-on-Tangible-Equity Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Green Fresh Biotechnology Co Return-on-Tangible-Equity Chart
HKSE:01084 vs ADM, BG, TSN: Return-on-Tangible-Equity Comparison
For the Farm Products subindustry, Green Fresh Biotechnology Co's Return-on-Tangible-Equity, along with its competitors' market caps and Return-on-Tangible-Equity data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Green Fresh Biotechnology Co Return-on-Tangible-Equity vs Consumer Packaged Goods Industry
For the Consumer Packaged Goods industry and Consumer Defensive sector, Green Fresh Biotechnology Co's Return-on-Tangible-Equity distribution charts can be found below:
* The bar in red indicates where Green Fresh Biotechnology Co's Return-on-Tangible-Equity falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Return-on-Tangible-Equity, the net income of the last fiscal year and the average total shareholder tangible equity over the fiscal year are used. In calculating the quarterly data,
the net income data used here is two times the semi-annual (Dec. 2025) net income data.
Return-on-Tangible-Equity is displayed in the 10-year financial page.
What does a Return-on-Tangible-Equity of 5.26% mean?
Green Fresh Biotechnology Co (HKSE:01084) has a Return-on-Tangible-Equity of 5.26% as of Dec. 2025. Return on tangible equity is the ratio of current-period net income to average two-period tangible equity. View historical data on Green Fresh Biotechnology Co and its competitors. This is 72% below median its historical median of 18.46. According to the industry distribution chart, Green Fresh Biotechnology Co ranks #1398 out of 1884 companies in the Consumer Packaged Goods industry, placing it in the top 74.2%.
Is Green Fresh Biotechnology Co's Return-on-Tangible-Equity too high?
Green Fresh Biotechnology Co's current Return-on-Tangible-Equity of 5.26% is 72% below median its 10-year median of 18.46. The Consumer Packaged Goods industry median Return-on-Tangible-Equity is 8.04. Green Fresh Biotechnology Co's value of 5.26% is 34.6% below this industry median. Based on the distribution chart, Green Fresh Biotechnology Co ranks #1398 out of 1884 companies in the Consumer Packaged Goods industry, which is below the industry midpoint. Overall, Green Fresh Biotechnology Co has a GF Score™ of 52/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Green Fresh Biotechnology Co's Return-on-Tangible-Equity compare to ADM and BG?
According to the Consumer Packaged Goods industry distribution chart, Green Fresh Biotechnology Co ranks #1398 out of 1884 companies for Return-on-Tangible-Equity. This places Green Fresh Biotechnology Co in the lower half of its industry. The industry median Return-on-Tangible-Equity is 8.04. Green Fresh Biotechnology Co's value of 5.26% is 34.6% below this benchmark. While the company's 10-year median is 18.46 vs. the industry median of 8.04, Green Fresh Biotechnology Co has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Return-on-Tangible-Equity for a Consumer Packaged Goods company?
The median Return-on-Tangible-Equity among Consumer Packaged Goods companies is 8.04, based on 1,884 companies in the industry. Companies in the top quartile (top 25%) have a Return-on-Tangible-Equity significantly above this median, while those in the bottom quartile fall well below. However, Return-on-Tangible-Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Green Fresh Biotechnology Co's current Return-on-Tangible-Equity of 5.26% is 34.6% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Return-on-Tangible-Equity mean?
A high Return-on-Tangible-Equity can signal that a stock is expensive relative to its fundamentals. Return on tangible equity is the ratio of current-period net income to average two-period tangible equity. View historical data on Green Fresh Biotechnology Co and its competitors. For the Consumer Packaged Goods industry, the median Return-on-Tangible-Equity is 8.04 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Green Fresh Biotechnology Co's current Return-on-Tangible-Equity is 5.26%, which is 72% below median its own 10-year median of 18.46. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Green Fresh Biotechnology Co stock overvalued right now?
Based on GuruFocus' analysis, Green Fresh Biotechnology Co (HKSE:01084) is currently considered Modestly Overvalued. The stock's GF Value™ is HK$0.55, compared to a current price of HK$0.68 — trading 23.6% above its estimated fair value. The current Return-on-Tangible-Equity is 5.26%, which is 72% below median its 10-year median of 18.46 and 34.6% below the Consumer Packaged Goods industry median of 8.04. Green Fresh Biotechnology Co's overall GF Score™ is 52/100 with 10 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Return-on-Tangible-Equity calculated?
Return-on-Tangible-Equity is calculated from a company's financial statements. For Green Fresh Biotechnology Co (HKSE:01084), the current Return-on-Tangible-Equity is 5.26% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Green Fresh Biotechnology Co (HKSE:01084) Overvalued in 2026?
Based on GuruFocus' analysis, Green Fresh Biotechnology Co stock appears to be overvalued.
The current stock price of HK$0.68 is trading 23.6% above its estimated GF Value™ of HK$0.55.
GuruFocus considers Green Fresh Biotechnology Co to be Modestly Overvalued.
Key valuation signals for HKSE:01084:
Return-on-Tangible-Equity: 5.26% (72% below median its 10-year median of 18.46)
GF Value™: HK$0.55 vs. price of HK$0.68 (23.6% above fair value)
Industry Position: 34.6% below the Consumer Packaged Goods median (#1398 of 1884)
No single metric tells the full story. See the HKSE:01084 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Green Fresh Biotechnology Co Ltd, formerly Green Future Food Hydrocolloid Marine Science Co Ltd is engaged in manufacturing and sales of food manufacturing hydrocolloid products including carrageenan products, agar-agar products, blended products, and konjac products in the People's Republic of China and overseas. Its segments include Manufacturing and sales of agar-agar products, which derives maximum revenue; Manufacturing and sales of carrageenan; Manufacturing and sales of konjac products; Manufacturing and sales of blended products; and Others, such as trading of seaweed powder and other operations. Its operations are spread across Chinese Mainland, which derives maximum revenue; Europe; Asia (excluding Chinese Mainland); South America; North America; Africa; and Oceania.
52GF Score
Get the complete analysis for HKSE:01084
Return-on-Tangible-Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HKSE:01084 has been successfully added to your 
